| Gabriela Mori, | |
|
95-390 Kuahelani Ave Ste 3e, Mililani, HI 96789-1190 | |
| (808) 637-2608 | |
| Not Available |
| Full Name | Gabriela Mori |
|---|---|
| Gender | Female |
| Speciality | Chiropractor |
| Location | 95-390 Kuahelani Ave Ste 3e, Mililani, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710750245 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | CHIR010818 (Georgia) | Secondary |
| 111N00000X | Chiropractor | DC-1599-0 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gabriela Mori, 91-1012 Kanehoalani St Apt D, Kapolei, HI 96707-3060 Ph: () - | Gabriela Mori, 95-390 Kuahelani Ave Ste 3e, Mililani, HI 96789-1190 Ph: (808) 637-2608 |
News Archive
The U.N. top aid chief "in Somalia has fired back at a report that suggests food aid is being skimmed off by contractors as 'a cost of doing business' in the war-torn nation, an allegation he calls 'completely misleading,'" CNN reports.
The price of new cancer drugs varies widely (from 28% to 388%) between high-income countries in Europe, Australia, and New Zealand, new research published in The Lancet Oncology has found.
An international collaboration involving researchers from Queen Mary University of London, Memorial Sloan Kettering Cancer Center, New York and Dana-Farber Cancer Institute, Boston has secured a €1M research grant from Dutch blood cancer charity, Lymph&Co, to investigate a new treatment target for lymphoma.
A recent short report from Canada, currently available on medRxiv* preprint server, shows a rapid increase in severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) cases characterized by the N501Y-/E484K- mutation in the Ontario province, which implies that Delta variant will rapidly overtake the Alpha variant.
Neurocrine Biosciences, Inc. announced today that NBI-77860, a proprietary corticotropin releasing factor 1 (CRF) receptor antagonist, has been granted orphan drug status by the United States Food and Drug Administration (FDA) for the treatment of congenital adrenal hyperplasia (CAH) a disease that affects approximately 20,000-30,000 people in the United States.
› Verified 6 days ago
Dr. Angeline Brutus, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 95-390 Kuahelani Ave Ste 3e, Mililani, HI 96789 Phone: 808-637-2608 | |
Antoinette Pualani Barbour, CHIROPRACTOR Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 95-390 Kuahelani Ave Ste 3e, Mililani, HI 96789 Phone: 808-376-2913 | |
Dr. Josuke Tanaka, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 95-745 Lauaki St, Mililani, HI 96789 Phone: 310-895-4887 | |
Downtown Chiropractic Clinic Chiropractor Medicare: Medicare Enrolled Practice Location: 95-720 Lanikuhana Ave, 240, Mililani, HI 96789 Phone: 808-625-0098 | |
Dr. Gonzalo Pineiro, Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 95-390 Kuahelani Ave Ste 3e, Mililani, HI 96789 Phone: 808-376-2913 Fax: 808-637-2643 | |
Family And Sports Chiropractic Center Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 94-1060 Anania Cir Apt 114, Mililani, HI 96789 Phone: 808-497-1729 |